It's official: Former Food and Drug Administration commissioner Robert Califf is taking on a new role with Verily, the life sciences arm of Alphabet, as CNBC reported yesterday. Califf announced today he will be an advisor to Verily, and he'll also rejoin Duke University, where he worked before he became the last FDA chief in the Obama administration. He's a friend of Verily CEO Andrew Conrad.
In a blog post, Califf said he wants to help Verily "offer insights that will allow the company to better tailor its technologies to meet the needs of doctors, other providers, health systems and the patients they serve, and to drive evidence-based approaches that will enable continuous learning and improvement."
